Bupropion occupancy of the dopamine transporter is low during clinical treatment

Psychopharmacology

Volumn 163, Issue 1, 2002, Pages 102-105

  Meyer, Jeffrey H ^a   Goulding, Verdell S ^a   Wilson, Alan A ^a   Hussey, Doug ^a   Christensen, Bruce K ^a   Houle, Sylvain ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bupropion; Depression; Dopamine transporter; Mood disorder; Positron emission tomography

Indexed keywords

AMFEBUTAMONE; DOPAMINE TRANSPORTER; RADIOPHARMACEUTICAL AGENT; RTI 32 C 11; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR OCCUPANCY;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COCAINE; DEPRESSIVE DISORDER; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROTEIN BINDING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036367835     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1166-3     Document Type: Article

References (31)

1. Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter
2. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism
3. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment
4. 3H] mazindol autoradiography
5. The effects of bupropion in vivo in the neostriatum of 5-day-old and adult rats
6. Bupropion in depression. II. The role of metabolites in clinical outcome
7. Bupropion slow-release response in depression: Diagnosis and biochemistry
8. The basal ganglia and adaptive motor control
9. 11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: Implications for the symptomatic threshold
10. A rating scale for depression
11. Lower dopamine transporter binding potential in striatum during depression
12. 11)C]DASB PET imaging study
13. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis
14. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites
15. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants
16. Cognitive and performance deficits in depression
17. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake
18. Limbic-striatal interactions in reward-related processes
19. Metabolism and kinetics of bupropion
20. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder
21. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures
22. Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs
23. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
24. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors
25. Relationship between subjective effects of cocaine and dopamine transporter occupancy
26. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
27. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients
28. 3]-carbomethoxy-3B-aryltropanes: Radiotracers for the dopamine transporter
29. 18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography